找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪(fǎng)問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Endocrine FGFs and Klothos; Makoto Kuro-o Book 2012 The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer S

[復(fù)制鏈接]
樓主: FERN
21#
發(fā)表于 2025-3-25 05:16:20 | 只看該作者
Jeffrey M. Bumpous,Mary Worthenors is also different for this sub-family, requiring klotho protein cofactors rather than heparin sulfate proteoglycan. Mouse Fgf15 and human FGF19 play key roles in enterohepatic signaling, regulation of liver bile acid biosynthesis, gallbladder motility and metabolic homeostasis.
22#
發(fā)表于 2025-3-25 11:00:52 | 只看該作者
,Klotho and βKlotho,rs and exert their biological activities. This chapter overviews function of Klotho family proteins as obligate coreceptors for endocrine FGFs and discusses potential link between Klothos and age-related diseases.
23#
發(fā)表于 2025-3-25 12:10:22 | 只看該作者
24#
發(fā)表于 2025-3-25 18:03:53 | 只看該作者
25#
發(fā)表于 2025-3-25 20:05:08 | 只看該作者
26#
發(fā)表于 2025-3-26 00:47:07 | 只看該作者
27#
發(fā)表于 2025-3-26 07:42:13 | 只看該作者
Evidence for FGF23 Involvement in a Bone-Kidney Axis Regulating Bone Mineralization and Systemic Phs through yet-to-be defined locally derived factors. In addition, FGF23 production is regulated by 1,25(OH)2D in a feedback loop where FGF23 stimulate Cyp24 mediated degradation of 1,25(OH)2D that serves to protect the organism from the toxic effects of vitamin D excess. In this chapter, we will review the regulation and function of FGF23.
28#
發(fā)表于 2025-3-26 08:34:54 | 只看該作者
Book 2012 affinity to FGF receptors in their target organs, the endocrine FGFs have designated the Klotho family of transmembrane proteins as obligate co-receptors. By expressing Klothos in a tissue-specific manner, this unique co-receptor system also enables the endocrine FGFs to specify their target organs among many tissues that express FGF receptors.
29#
發(fā)表于 2025-3-26 15:07:12 | 只看該作者
30#
發(fā)表于 2025-3-26 17:51:39 | 只看該作者
https://doi.org/10.1007/978-3-662-33866-7 and lack of apparent side effects in a variety of animal models. Thus, FGF21 represents a novel and appealing therapeutic reagent for Type 2 diabetes mellitus, obesity, dyslipidemia, cardiovascular and fatty liver diseases. The in vitro biology, genetic animal models and in vivo pharmacology of FGF21 will be discussed in this chapter.
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-29 23:59
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
隆林| 南康市| 濮阳县| 大余县| 泸定县| 广丰县| 金沙县| 江阴市| 文山县| 惠水县| 哈尔滨市| 大石桥市| 黄平县| 通道| 利川市| 承德县| 广丰县| 枣阳市| 新河县| 龙川县| 靖州| 玉龙| 乌兰察布市| 惠水县| 石渠县| 丹凤县| 海安县| 朝阳市| 浦江县| 五莲县| 晴隆县| 太仓市| 平原县| 瑞昌市| 灵台县| 肥乡县| 绥化市| 巴青县| 英山县| 马关县| 黄大仙区|